share_log

復星醫藥:海外監管公告-中國國際金融股份有限公司關於上海復星醫藥(集團)股份有限公司2023年度持續督導現場檢查報告

FOSUN PHARMA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

香港交易所 ·  Apr 2 05:53
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more